Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1964 Jul;43(7):1419–1423. doi: 10.1172/JCI105017

Studies of Sulfobromophthalein Sodium (BSP) Metabolism in Man. II. The Effect of Artificially Induced Fever, Norethandrolone (Nilevar), and Iopanoic Acid (Telapaque)*

Leslie J Schoenfield 1, William T Foulk 1
PMCID: PMC289617  PMID: 14192522

Full text

PDF
1422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOLT R. J., DILLON R. S., POLLARD H. M. Interference with bilirubin excretion by a gall-bladder dye (bunamiodyl). N Engl J Med. 1961 Nov 23;265:1043–1045. doi: 10.1056/NEJM196111232652105. [DOI] [PubMed] [Google Scholar]
  2. COMBES B., STAKELUM G. S. A liver enzyme that conjugates sulfobromophthalein sodium with glutathione. J Clin Invest. 1961 Jun;40:981–988. doi: 10.1172/JCI104337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HEANEY R. P., WHEDON G. D. Impairment of hepatic bromsulphalein clearance by two 17-substituted testosterones. J Lab Clin Med. 1958 Aug;52(2):169–175. [PubMed] [Google Scholar]
  4. Hicks M. H., Holt H. P., Guerrant J. L., Leavell B. S. THE EFFECT OF SPONTANEOUS AND ARTIFICIALLY INDUCED FEVER ON LIVER FUNCTION. J Clin Invest. 1948 Sep;27(5):580–587. doi: 10.1172/JCI102003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. KORY R. C., BRADLEY M. H., WATSON R. N., CALLAHAN R., PETERS B. J. A six-month evaluation of an anabolic drug, norethandrolone, in underweight persons. II. Bromsulphalein (BSP) retention and liver function. Am J Med. 1959 Feb;26(2):243–248. doi: 10.1016/0002-9343(59)90313-4. [DOI] [PubMed] [Google Scholar]
  6. LEEVY C. M., CHERRICK G. R., DAVIDSON C. S. Observations on norethandrolone-induced abnormalities in plasma decay of sulfobromophthalein and indocvanine green. J Lab Clin Med. 1961 Jun;57:918–926. [PubMed] [Google Scholar]
  7. MARQUARDT G. H., FISHER C. I., LEVY P., DOWBEN R. M. Effect of anabolic steroids on liver function tests and creatine excretion. JAMA. 1961 Mar 11;175:851–853. doi: 10.1001/jama.1961.03040100015005. [DOI] [PubMed] [Google Scholar]
  8. SCHAFFNER F., POPPER H., CHESROW E. Cholestasis produced by the administration of norethandrolone. Am J Med. 1959 Feb;26(2):249–254. doi: 10.1016/0002-9343(59)90314-6. [DOI] [PubMed] [Google Scholar]
  9. SCHERB J., KIRSCHNER M., ARIAS I. Studies of hepatic excretory function. The effect of 17alpha-ethyl-19-nortestosterone on sulfobromophthalein sodium (BSP) metabolism in man. J Clin Invest. 1963 Mar;42:404–408. doi: 10.1172/JCI104727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SCHOENFIELD L. J., FOULK W. T., BUTT H. R. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE. J Clin Invest. 1964 Jul;43:1409–1418. doi: 10.1172/JCI105016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. WHEELER H. O., MELTZER J. I., BRADLEY S. E. Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease. J Clin Invest. 1960 Jul;39:1131–1144. doi: 10.1172/JCI104128. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES